Cardiff Oncology Announces The Appointment Of Two New Independent Members To Its Board Of Directors

by posted 1month ago 10 views
SAN DIEGO, June 10, 2021 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical needs for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer and...

In this article

No tags related to this article.